This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

John H. Bauer, MD; Louise B. Jones, RN; Patricia Gaddy, RN

Arch Intern Med. 1984;144(6):1196-1200.

Abstract
• To our knowledge, the long-term effects of prazosin hydrochloride, an ₁-adrenoceptor antagonist, on renal function and body fluid composition have not been previously reported. Fourteen hypertensive men in whom the BP was normalized with prazosin monotherapy, underwent assessment of renal function and body fluid composition following short-term (three to six weeks), long-term (five to six months), and withdrawal (two weeks) therapy. Neither short- nor long-term prazosin therapy had any adverse effect on the glomerular filtration rate or effective renal plasma flow. Renal vascular resistance was decreased 14% during short-term therapy, but not during long-term therapy. Urine flow rate, urine osmolality, free water clearance, and fractional sodium and potassium excretions were statistically unchanged throughout drug therapy. Plasma volume and extracellular fluid volume were increased following both short- and long-term therapy. Long-term prazosin monotherapy effectively lowers BP without resulting in drug tolerance, however, sodium retention probably limits its antihypertensive effectiveness.

(Arch Intern Med 1984;144:1196-1200)

Author Affiliations
From the Medical (Dr Bauer) and Nursing Services (Ms Gaddy), Harry S. Truman Memorial Veterans Hospital; and the Department of Medicine, University of Missouri School of Medicine (Dr Bauer and Ms Jones), Columbia, Mo.

Footnotes
Accepted for publication Nov 17, 1983.

Reprint requests to the Department of Medicine, Division of Nephrology, University of Missouri School of Medicine, Columbia, MO 65212 (Dr Bauer).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Fluid Matters in Choosing Antihypertensive Therapy: A Hypothesis That the Data Speak Volumes
Blankfield
J Am Board Fam Med 2005;18:113-124.
ABSTRACT | FULL TEXT  

Long-term Effects of Antihypertensive Agents on Proteinuria and Renal Function
Maki et al.
Arch Intern Med 1995;155:1073-1080.
ABSTRACT  

{alpha}-Blocker Therapy of Hypertension: An Unfulfilled Promise
Khoury and Kaplan
JAMA 1991;266:394-398.
ABSTRACT